Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
发布时间: 2020 - 09 - 04
点击次数: 0
Positions: MBA, CFA
Company: I-Mab
个人简介:
As the Chief Financial Officer, Jielun Zhu, MBA, CFA, is in charge of the overall financial strategy and management, capital investment, corporate finance and investor relations. He is a veteran and expert in the finance industry, with over 11 years of experience in investment banking. From December 2015 to July 2018, prior to joining I-Mab, he served as a managing director and Asia Head of Healthcare Investment Banking and Capital Markets in Hong Kong for Jefferies Group LLC, a global full-service investment bank with a strong focus in healthcare.At Jefferies, Mr. Zhu advised many biotechnology and healthcare clients globally on IPOs and other financings, as well as mergers and acquisitions. From August 2008 to September 2015, he worked for the Deutsche Bank Group in its Hong Kong office, occupying a succession of positions culminating in Director in the Corporate Finance Division, which entailed working with leading clients in the healthcare and other sectors in Greater China. From July 2007 to July 2008, he was an investment banker in Hong Kong with UBS AG. Before investment banking, Mr. Zhu was a strategy consultant in Boston focused on serving clients in the US pharmaceutical and biotechnology industry.Mr. Zhu earned his MBA from Harvard Business School with distinction in June 2007 and his Bachelor of Arts degree with honors in mathematics-economics from Wesleyan University. He is also a Chartered Financial Analyst (CFA) charter holder.
发布时间: 2020 - 09 - 04
点击次数: 0
Positions: Vice President, Global Issuer Services
Company: Hong Kong Exchanges and Clearing Limited
个人简介:
Ms. Zhang joined the Listing Department of HKEx in 2011 and was responsible for processing applications for IPO listing application, and coordinating listing policy initiatives and developments.  Ms. Zhang internally transferred to Beijing Representative Office since August 2015. Her key focus is on market development introducing and promoting the HKEX IPO platform to corporates, investors and financial institutions in Mainland China.
发布时间: 2020 - 09 - 04
点击次数: 0
Positions: Chief Business Officer
Company: Harbour BioMed
个人简介:
Dr. Mai-Jing Liao brings to HBM more than 12 years of Marketing and Business Development experience. Prior to joining HBM, Dr. Liao was at Xian Janssen Pharmaceutical Ltd. where he served in multiple roles with increasing responsibilities in Marketing, Strategic Marketing and Business Development. He joined J&J's Centocor US subsidiary after receiving his MBA degree from Johnson Graduate School of Management at Cornell University.  Dr. Liao received his PhD degree in Biochemistry and Biophysics from the University of North Carolina at Chapel Hill and was a postdoctoral fellow in Dr. Robert Weinberg's laboratory at Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology (MIT).
发布时间: 2020 - 09 - 04
点击次数: 0
Positions: VP of Business Development
Company: Innovent Biologics
个人简介:
Blake Salisbury currently leads BD activities as the VP of Business Development at Innovent Biologics, a China based innovative biopharmaceutical company.  Blake has 27 years of experience in pharma/biotech, primarily in business development (20 years), but also in sales, marketing, and pricing. While at Innovent, Blake has in-licensed and out-licensed various early stage assets to/from partners in China, he led a global co-development deal to develop and commercialize a bispecific antibody with Hanmi Pharmaceuticals, and in 2018 he in-licensed 3 late stage oncology small molecules from Incyte for the China market. Prior to joining Innovent, Blake spent almost 24 years with Eli Lilly and Company where he closed over 50 transactions of various types, many of which were notable transactions with Chinese companies, starting as early as 2006.  Blake’s last position at Lilly was as a Senior Director of Corporate Business Development – responsible for in-license, out-license, and M&A activities supporting Lilly’s various Business Units.
9页次2/3首页Previous123Next尾页